Celltrion Completes Resubmission for Biosimilar Candidate to FDA for Review | Business Wire
Celltrion, Teva announce FDA approval of HERZUMA
Celltrion and Teva Snag Second Biosimilar Approval of a Genentech Drug | BioSpace
Teva, Celltrion win FDA approval for Rituxan biosimilar - Globes
Teva bolsters its biosimilar business through $160m Celltrion deal
Biosimilars: Celltrion paves way for Herceptin copycats in 2018 - Pharmaceutical Technology
FDA approves first Rituxan biosimilar courtesy of Teva and Celltrion | Pharmafile
Amgen and Allergan's Kanjinti (trastuzumab-anns) Biosimilar Product Profile
Jobs with Celltrion Healthcare (Formerly Known As Celltrion) | page 2
Teva, Celltrion launch Herceptin biosimilar in US - Globes
Teva teams up on biosims with Celltrion three years after its Lonza JV divorce | Fierce Biotech
Teva and Celltrion Announce Exclusive Biosimilar Commercial Partnership | World Pharma Today
Celltrion launches Herceptin biosimilar in US
New data raise profile of Truxima at EHA 2021
Teva confident in September approval for migraine drug despite latest Celltrion plant citation | Fierce Pharma
Celltrion says COVID-19 antibody kills virus within 5 days; shares surge - KED Global
Celltrion's Q3 earnings beat market consensus to hit record high - KED Global
Celltrion/Teva's Herceptin biosimilar approved in US -
Teva: Migraine Mab Delay After 'Negative Surprise' of Celltrion Warning - BioProcess InternationalBioProcess International
Teva, Celltrion get FDA nod for biosimilar to Roche's cancer drug Rituxan
Teva and Celltrion Launch Truxima (biosimilar- rituximab) to Treat Wegener's Granulomatosis and Microscopic Polyangiitis in the US
Teva buys US rights to Celltrion biosimilars -
FiercePharmaAsia—China's new drug regulator, Teva's Celltrion headache, NextCODE-Google tie-up | Fierce Pharma
Teva and Celltrion Healthcare Announce the Launch of TRUXIMA® (rituximab-abbs) Injection for Rheumatoid Arthritis, the Only Biosimilar to Rituxan® (ri
Teva, Celltrion Partner | Technology Networks
Teva two: FDA approves Celltrion-made Herceptin biosimilar - BioProcess InternationalBioProcess International
Teva and Celltrion Announce the Availability of TRUXIMA® (rituximab-abbs) Injection, the First Biosimilar to Rituxan® (rituximab) in the United States | Business Wire
